MEDIFAST (MED)
(Delayed Data from NYSE)
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Service Corporation's (SCI) Shareholder-Friendly Moves Bode Well
by Zacks Equity Research
Service Corporation (SCI) has been focused on boosting shareholder returns through dividend payments and share buybacks. The company boosts its repurchase authorization.
Boston Beer (SAM) Plans to Develop Cannabis Research Hub
by Zacks Equity Research
Boston Beer (SAM) looks to tap the opportunities in the cannabis space. It is on track to create a subsidiary to conduct research and innovation in Canada on non-alcoholic cannabis beverages.
What Makes Medifast (MED) a Good Fit for "Trend Investing"
by Zacks Equity Research
Medifast (MED) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
General Mills (GIS) to Buy Tyson Foods' Pet Treats Business
by Zacks Equity Research
General Mills' (GIS) to acquire Tyson Foods' pet treats business by first-quarter fiscal 2022. The acquisition is in tandem with its Accelerate strategy.
B&G Foods (BGS) Q1 Earnings Miss Estimates, Sales Rise Y/Y
by Zacks Equity Research
B&G Foods (BGS) first-quarter fiscal 2021 results reflect higher earnings and sales on contribution from Crisco acquisition as well as persistent strength in base business net sales.
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.
Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.
Coty (COTY) Q3 Earnings Match Estimates, Revenues Decline Y/Y
by Vrishali Bagree
Coty's (COTY) third-quarter fiscal 2021 results reflect lower revenues due to the pandemic-related woes, especially in Western Europe. However, cost-saving actions aid the bottom line.
Tyson Foods (TSN) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) second-quarter 2021 sales and earnings rise year over year on revenue growth across all segments. However, inflation across supply chain is a headwind.
Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
TreeHouse Foods (THS) Q1 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
TreeHouse Foods' (THS) first-quarter 2021 results reflect lower retail demand due to tough year-over-year comparisons and inflationary pressure.
Hain Celestial (HAIN) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Hain Celestial's (HAIN) Q3 earnings reflect gains from improved margin performance and lower effective tax rate. It witnesses strong adjusted gross and EBITDA margin growth in the reported quarter
Post Holdings (POST) Q2 Earnings Miss, Sales Beat Estimates
by Zacks Equity Research
Post Holdings' (POST) Q2 results reflect declines in the Post Consumer Brands and Foodservice businesses. Also, comparison with last year's increased pantry-loading due to the pandemic hurt results.
The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television
Grab These 5 Quality Stocks Screened on DuPont Analysis
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
5 Mid-Cap Stocks That Reported Solid Q1 Results
by Sejuti Banerjea
Diversify your portfolio to include some mid-cap stocks.
Kellogg (K) Q1 Earnings & Sales Top Estimates, Guidance Raised
by Zacks Equity Research
Kellogg's (K) first-quarter 2021 results reflect solid earnings and sales growth, along with a raised guidance for 2021. Strength in the retail business continues to aid.
Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View
by Zacks Equity Research
Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.
Medifast (MED) Moves 12.1% Higher: Will This Strength Last?
by Zacks Equity Research
Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Medifast (MED) Stock Gains on Q1 Earnings & Revenue Beat
by Zacks Equity Research
Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.
Medifast (MED) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 27.21% and 18.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
ADM (ADM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
ADM (ADM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
If You Invested $1000 in Medifast a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Kellogg (K) Lined Up for Q1 Earnings: Key Factors to Watch
by Zacks Equity Research
Kellogg's (K) first-quarter 2021 results are likely to reflect softness in the foodservice business due to weak away-from-home food demand, though at-home consumption is likely to benefit the retail business.